Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Citi
UBS
Boehringer Ingelheim
Teva

Generated: April 22, 2019

DrugPatentWatch Database Preview

SOMATROPIN RECOMBINANT - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for somatropin recombinant and what is the scope of somatropin recombinant patent protection?

Somatropin recombinant is the generic ingredient in eighteen branded drugs marketed by Emergent, Pharmacia And Upjohn, Lilly, Novo Nordisk Inc, Genentech, Sandoz, Emd Serono, and Lg Chem Ltd, and is included in thirteen NDAs. There are nineteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Somatropin recombinant has one hundred and eighty-one patent family members in twenty-two countries.

There are four drug master file entries for somatropin recombinant. Six suppliers are listed for this compound.

Pharmacology for SOMATROPIN RECOMBINANT

US Patents and Regulatory Information for SOMATROPIN RECOMBINANT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-008 Mar 1, 2010 BX RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-008 Mar 1, 2010 BX RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 021148-002 Jun 20, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-011 Jan 23, 2015 RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for SOMATROPIN RECOMBINANT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 021148-001 Jun 20, 2000 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-004 Aug 24, 1995 ➤ Sign Up ➤ Sign Up
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-004 Dec 1, 2003 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-012 Jan 27, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Argus Health
Boehringer Ingelheim
QuintilesIMS
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.